General Information
DRAVP ID DRAVPe01769
Peptide Name CMK
Sequence RVKR
Sequence Length 4
UniProt ID No entry found
Source Synthetic construct
Activity Information
Target Organism SARS-CoV-2
Assay Plaque assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target Not found
Mechanism CMK blocks virus entry, but it further suppresses cleavage of spikes and the syncytium.
Structure Information
PDB ID None
Predicted Structure Download No predicted structure available
Linear/Cyclic Linear
N-terminal Modification Decanoyl(C10)
C-terminal Modification chloromethylketone(CMK)
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C23H47N11O5
Absent amino acids ACDEFGHILMNPQSTWY
Common amino acids R
Mass 557.7
Pl 12.01
Basic residues 3
Acidic residues 0
Hydrophobic residues 1
Net charge 3
Boman Index -3135
Hydrophobicity -217.5
Aliphatic Index 72.5
Half Life
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Literature Information
Literature 1
Title Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
Pubmed ID 23617302
Reference Liver Int. 2013 Sep;33(8):1230-8.
Author Pang YJ, Tan XJ, Li DM, Zheng ZH, Lei RX, Peng XM.
Literature 2
Title Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
Pubmed ID 31683742
Reference Viruses. 2019 Oct 31;11(11):1011.
Author Imran M, Saleemi MK, Chen Z, Wang X, Zhou D, Li Y, Zhao Z, Zheng B, Li Q, Cao S, Ye J.
Literature 3
Title Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
Pubmed ID 33007239
Reference Cell Rep. 2020 Oct 13;33(2):108254.
Author Cheng YW, Chao TL, Li CL, Chiu MF, Kao HC, Wang SH, Pang YH, Lin CH, Tsai YM, Lee WH, Tao MH, Ho TC, Wu PY, Jang LT, Chen PJ, Chang SY, Yeh SH.